Brandinium

Trademark search for:

RA PHARMA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-01-06 — Application filed
  • 2016-01-09 — Application filed
  • 2016-01-14 — Application filed
  • 2016-01-15 — Notice of design search code e-mailed
  • 2016-04-21 — Assigned to examiner
  • 2016-04-22 — Assigned to lie
  • 2016-04-26 — Data modification completed
  • 2016-04-27 — Examiners amendment -written
  • 2016-04-27 — Examiners amendment e-mailed
  • 2016-04-27 — Notification of examiners amendment e-mailed
  • 2016-04-27 — Examiner's amendment entered
  • 2016-04-27 — Approved for pub - principal register
  • 2016-05-09 — Law office publication review completed
  • 2016-05-25 — Notification of notice of publication e-mailed
  • 2016-06-14 — Published for opposition
  • 2016-06-14 — Official gazette publication confirmation e-mailed
  • 2016-07-27 — Teas change of correspondence received
  • 2016-08-09 — Noa e-mailed - sou required from applicant
  • 2016-08-24 — Teas change of owner address received
  • 2016-08-24 — Applicant/correspondence changes (non-responsive) entered
  • 2017-01-23 — Teas change of correspondence received
  • 2017-01-23 — Sou teas extension received
  • 2017-01-23 — Sou extension 1 filed
  • 2017-01-23 — Sou extension 1 granted
  • 2017-01-25 — Notice of approval of extension request e-mailed
  • 2017-07-10 — Teas statement of use received
  • 2017-07-10 — Use amendment filed
  • 2017-08-03 — Case assigned to intent to use paralegal
  • 2017-08-03 — Statement of use processing complete
  • 2017-08-24 — Allowed principal register - sou accepted
  • 2017-08-25 — Notice of acceptance of statement of use e-mailed
  • 2017-09-26 — Registered-principal register
  • 2020-09-01 — Teas revoke/app/change addr of atty/dom rep received
  • 2020-09-01 — Attorney/dom.rep.revoked and/or appointed
  • 2020-09-01 — Teas change of correspondence received
  • 2021-10-25 — Teas revoke/app/change addr of atty/dom rep received
  • 2021-10-25 — Attorney/dom.rep.revoked and/or appointed
  • 2021-10-25 — Teas withdrawal of attorney received-firm retains
  • 2021-10-25 — Teas change of correspondence received
  • 2022-07-07 — Teas change of owner address received
  • 2022-07-07 — Teas change of correspondence received
  • 2022-07-07 — Teas revoke/app/change addr of atty/dom rep received
  • 2022-07-07 — Teas withdrawal of attorney received-firm retains
  • 2022-07-07 — Attorney/dom.rep.revoked and/or appointed
  • 2022-07-07 — Applicant/correspondence changes (non-responsive) entered
  • 2022-09-26 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2024-04-05 — Cancelled sec. 8 (6-yr)
  • 2024-04-05 — Final status recorded

Owner Information

Ra Pharmaceuticals, Inc.
Cambridge , MA
Ra Pharmaceuticals, Inc.
Cambridge , MA
Ra Pharmaceuticals, Inc.
Cambridge , MA

Correspondent

Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.
1025 Connecticut Avenue NW, Suite 500
Washington, DC 20036
UNITED STATES

Filing Details

Filing Date:
2016-01-06
Status Date:
2024-04-05
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.